EGOI-PCOS
  • The Group
    • Experts on Inositol
    • Experts on PCOS
    • Mission
    • Regulations and Statute
  • Clinical Centers
  • Publications
  • Activities
    • Fellowship
  • Affiliations
    • Support
  • Register
  • Login
Select Page

Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS

Feb 3, 2025

Authors: Quaresima P, Myers SH, Pintaudi B, D’Anna R, Morelli M and Unfer V

Myo-Inositol and Its Derivatives: Their Roles in the Challenges of Infertility

Nov 16, 2024

Authors: Martina Placidi, Giovanni Casoli, Carla Tatone, Giovanna Di Emidio and Arturo Bevilacqua

The effects of Myo-inositol and D-chiro-inositol in a ratio 40:1 on hormonal and metabolic profile in women with PCOS classified as phenotype A by the Rotterdam Criteria and EMS-type 1 by the EGOI Criteria

Jan 31, 2024

Authors: Olga Pustotina, Samuel H. Myers, Vittorio Unfer, Irina Rasulova

Comparing the Efficacy of Myo-Inositol Plus -Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome

May 31, 2023

Authors: Zdravko Kamenov, Antoaneta Gateva, Simona Dinicola, and Vittorio Unfer

D-Chiro-Inositol and Myo-Inositol Induce WAT/BAT Trans-Differentiation in Two Different Human Adipocyte Models (SGBS and LiSa-2)

Apr 18, 2023

Authors: Giovanni Monastra, Riccardo Gambioli, Vittorio Unfer, Gianpiero Forte, Elsa Maymo-Masip, Raffaella Comitato
« Older Entries


Viale di Villa Massimo 37, 00161, Rome (Italy)
Email: office@egoipcos.com or info@egoipcos.com
P.IVA / VAT ID: 96501700585

Subscribe to our Newsletter

Terms of use

Privacy and Cookie Policy
Registration Privacy Policy

All Rights Reserved ©2020 The Experts Group on Inositols in Basic and Clinical Research (EGOI)